Phospho-SRC (Ser75) Antibody

What is SRC and what is the significance of Ser75 phosphorylation?

SRC is a 60kDa proto-oncogene tyrosine-protein kinase that plays critical roles in regulating embryonic development, cell growth, and neuronal function. Ser75 phosphorylation occurs in the N-terminal Unique domain of SRC, which shares no homology with other SRC family kinases. This phosphorylation site is particularly significant because it regulates the stability and activation state of SRC. Phosphorylation at Ser75 by Cyclin-dependent kinases (CDK1 in fibroblasts during mitosis or CDK5 in post-mitotic neurons) targets SRC for ubiquitin-dependent degradation, thus leading to cytoskeletal reorganization .

What are the key enzymes responsible for phosphorylating SRC at Ser75?

SRC Ser75 is phosphorylated by:

• Cyclin-dependent kinase 1 (Cdk1) in fibroblasts and during mitosis

• Cyclin-dependent kinase 5 (Cdk5) in differentiated neurons and certain tumor cell lines of neuronal origin

Cdk5/p35 has the same consensus sequence as Cdk1 and has been shown to phosphorylate Ser75 in human Y79 retinoblastoma cells and in in vitro phosphorylation assays . This phosphorylation is particularly important in post-mitotic neurons where it occurs in a mitosis-independent manner .

How does SRC Ser75 phosphorylation differ from other regulatory phosphorylation sites on SRC?

SRC function is regulated by multiple phosphorylation events that impact its activity and stability:

Unlike tyrosine phosphorylation sites (Tyr419 and Tyr530) that directly control kinase activity, Ser75 phosphorylation primarily regulates SRC protein stability and downstream signaling pathways such as ROCK activation .

What are the optimal methods for using Phospho-SRC (Ser75) antibodies in Western blot applications?

For optimal Western blot detection of Phospho-SRC (Ser75):

• Sample preparation:

  • Use fresh tissue or cell lysates

  • Include phosphatase inhibitors in lysis buffer

  • For brain tissue samples, homogenize in buffer containing protease inhibitors and centrifuge at 100,000 × g for 40 minutes at 4°C

• Protocol recommendations:

  • Protein amount: 15-20 μg per lane

  • Gel concentration: 4-15% SDS-PAGE gels

  • Antibody dilution range: 1:500-1:2000 (verify optimal dilution for your specific antibody)

  • Incubation: 18 hours at 4°C for primary antibody

  • Detection: HRP-conjugated secondary antibodies with ECL detection systems

• Controls:

  • Include a blocking peptide control (antigen-specific peptide) to verify specificity

  • Consider using lysates from cells treated with phosphorylation-inducing agents (e.g., EGF treatment)

What validation methods should be performed to confirm antibody specificity for phosphorylated Ser75?

To validate the specificity of Phospho-SRC (Ser75) antibodies, researchers should:

• Perform peptide competition assays:

  • Pre-incubate the antibody with the immunizing phosphopeptide

  • Compare signal between blocked and unblocked antibody samples

  • Absence of signal in the peptide-blocked sample confirms specificity

• Use genetic models:

  • Compare samples from wild-type mice with those from Ser75Ala (non-phosphorylatable) mutants

  • The antibody should show no reactivity with samples from Ser75Ala mutants

• Analyze phosphatase-treated samples:

  • Treat half of your sample with lambda phosphatase

  • Loss of signal after phosphatase treatment confirms phospho-specificity

• Employ stimulation/inhibition experiments:

  • Use CDK5 activators or inhibitors to modulate Ser75 phosphorylation

  • Observe corresponding changes in antibody signal intensity

How should researchers design experiments to study the functional consequences of SRC Ser75 phosphorylation?

When designing experiments to study the functional impact of SRC Ser75 phosphorylation, consider:

• Genetic approaches:

  • Generate or utilize knock-in mice with Ser75Ala (non-phosphorylatable) or Ser75Asp (phosphomimetic) mutations

  • Compare phenotypes between these models to determine phosphorylation-dependent effects

• Signaling pathway analysis:

  • Measure ROCK activity using the MYPT1 phosphorylation assay

  • Assess Akt phosphorylation at Ser473

  • These downstream effectors are differentially regulated by Ser75 phosphorylation status

• Behavioral assays:

  • For neuronal studies, utilize ethanol consumption preference tests

  • Measure plasma ethanol concentrations

  • Assess sensitivity to sedative effects

• Cellular morphology and survival studies:

  • In retinal studies, quantify RGC number in different retinal regions

  • Compare age-dependent changes between wild-type and phospho-mutant models

How does SRC Ser75 phosphorylation affect ethanol consumption behavior in mouse models?

Research using genetically modified mice has revealed that SRC Ser75 phosphorylation status significantly impacts ethanol consumption behavior:

• Mice harboring the non-phosphorylatable Ser75Ala (SA) SRC mutation:

  • Demonstrated higher preference for solutions containing 5% and 10% ethanol compared to wild-type mice

  • Showed increased consumption of ethanol-containing solutions

  • Displayed no differences in plasma ethanol concentrations or sensitivities to sedative effects of ethanol

• Mice with phosphomimetic Ser75Asp (SD) SRC mutation:

  • Showed no significant differences in ethanol preference or consumption compared to wild-type mice

• Molecular mechanisms involved:

  • SA mutant mice exhibited significantly lower ROCK activity in the striatum

  • SA mutant mice showed higher Akt Ser473 phosphorylation compared to wild-type mice

  • These findings suggest that Src regulates voluntary ethanol drinking through modulation of ROCK and Akt signaling pathways in a manner dependent on Ser75 phosphorylation status

What role does SRC Ser75 phosphorylation play in retinal ganglion cell survival during aging?

SRC Ser75 phosphorylation has been implicated in age-dependent retinal ganglion cell (RGC) survival:

• Phosphomimetic Ser75Asp (SD/SD) mice:

  • Exhibited significant age-related RGC loss in whole retinas

  • Showed greater RGC reduction in peripheral versus mid-peripheral retinal regions

  • Developed progressive optic neuropathy-like pathology in the absence of inflammation or elevated intraocular pressure

• Non-phosphorylatable Ser75Ala (SA/SA) mice:

  • Showed no significant age-related RGC loss, similar to wild-type mice

• Molecular mechanisms:

  • Rho-associated kinase (ROCK) activity in whole retinas of aging SD/SD mice was significantly higher than in young SD/SD mice

  • This suggests that SRC Ser75 phosphorylation modulates ROCK activity, which in turn affects RGC survival during aging

How does SRC Ser75 phosphorylation affect ROCK activity and downstream signaling?

SRC Ser75 phosphorylation regulates ROCK activity and downstream signaling through several mechanisms:

• Direct effects on ROCK activation:

  • SRC phosphorylated at Ser75 by CDK5 increases ROCK activity in vitro

  • Mice with phosphomimetic Ser75Asp mutations show higher ROCK activity in retinal tissue compared to wild-type or Ser75Ala mutants

• Impact on Akt signaling:

  • Mice with non-phosphorylatable Ser75Ala mutations exhibit higher Akt Ser473 phosphorylation in the striatum

  • This suggests that SRC Ser75 phosphorylation may negatively regulate Akt activation

• Feedback regulation:

  • SRC Ser75 phosphorylation promotes ubiquitin-mediated degradation of activated SRC

  • This regulatory mechanism may serve to modulate the duration and intensity of SRC signaling in neurons

What are common challenges when detecting SRC Ser75 phosphorylation and how can they be addressed?

Common challenges and their solutions include:

• Low signal intensity:

  • Ensure phosphatase inhibitors are fresh and properly included in all buffers

  • Optimize antibody concentration (try 1:500 instead of 1:1000)

  • Increase protein loading (20-30 μg)

  • Extend primary antibody incubation time to overnight at 4°C

  • Use enhanced chemiluminescence detection systems

• High background:

  • Increase blocking time with 2-5% BSA or non-fat dry milk

  • Add 0.1% Tween-20 to all washing steps

  • Dilute primary antibody in fresh blocking buffer

  • Consider using alternative secondary antibodies with lower background

• Non-specific bands:

  • Always include blocking peptide controls

  • Use gradient gels (4-15%) for better separation

  • Verify molecular weight (expected ~60 kDa for SRC)

  • Consider using SRC knockout or Ser75Ala mutant samples as negative controls

How should researchers interpret contradictory results between phospho-SRC (Ser75) levels and functional outcomes?

When faced with contradictory results:

• Verify antibody specificity:

  • Confirm that the antibody specifically detects phosphorylated Ser75 using appropriate controls

  • Rule out cross-reactivity with other phosphorylated residues in SRC or related kinases

• Consider temporal dynamics:

  • Phosphorylation may be transient; establish a time course experiment

  • Phosphorylation might precede degradation of SRC, so total SRC levels should be monitored alongside phospho-SRC levels

• Examine tissue/cell-specific effects:

  • Ser75 phosphorylation effects may vary between cell types (neurons vs. fibroblasts)

  • Compare results across multiple tissue types and experimental models

• Analyze multiple downstream pathways:

  • Simultaneously assess ROCK activity and Akt phosphorylation

  • Different downstream pathways may be differentially affected by Ser75 phosphorylation status

What experimental design approaches can help isolate the specific effects of SRC Ser75 phosphorylation from other SRC regulatory mechanisms?

To isolate Ser75 phosphorylation effects:

• Use genetically modified models:

  • Employ knock-in mice with Ser75Ala (SA) or Ser75Asp (SD) mutations

  • These models specifically alter Ser75 phosphorylation while preserving other regulatory mechanisms

• Employ pharmacological approaches:

  • Use CDK5-specific inhibitors to reduce Ser75 phosphorylation

  • Combine with tools that modulate tyrosine phosphorylation (CSK inhibitors, phosphatase inhibitors)

  • This approach allows temporal control over different phosphorylation events

• Design rescue experiments:

  • Express wild-type or mutant SRC in SRC-deficient backgrounds

  • Compare the ability of different SRC variants to rescue phenotypes

  • This approach can establish causality between specific phosphorylation sites and functional outcomes

• Utilize phosphorylation state-specific assays:

  • Combine immunoprecipitation with Phospho-SRC (Ser75) antibodies

  • Analyze the phosphorylation status of other sites in the immunoprecipitated fraction

  • This approach helps determine how different phosphorylation events interact